Skip to Content

AN 1261 (Fenofibrate 145 mg)

Pill with imprint AN 1261 is White, Elliptical / Oval and has been identified as Fenofibrate 145 mg. It is supplied by Amneal Pharmaceuticals LLC.

Fenofibrate is used in the treatment of hypertriglyceridemia; hyperlipoproteinemia type iia, elevated ldl; hyperlipoproteinemia type iv, elevated vldl; hyperlipoproteinemia type iib, elevated ldl vldl; hyperlipoproteinemia type v, elevated chylomicrons vldl and belongs to the drug class fibric acid derivatives. Risk cannot be ruled out during pregnancy. Fenofibrate 145 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for AN 1261

Fenofibrate 145 mg AN 1261

Fenofibrate

Imprint
AN 1261
Strength
145 mg
Color
White
Size
18.00 mm
Shape
Elliptical / Oval
Availability
Prescription only
Drug Class
Fibric acid derivatives
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Amneal Pharmaceuticals LLC
National Drug Code (NDC)
69238-1261
Inactive Ingredients
crospovidone, hypromelloses, lactose monohydrate, magnesium stearate, microcrystalline cellulose, sodium benzoate, sodium lauryl sulfate, sucrose, polyethylene glycol, magnesium silicate, titanium dioxide, soya lecithin

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Related Images for "AN 1261"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.